What can be concluded about a patient's kidney function with impaired renal function (eGFR in the upper 50's, stage 3a) based on a creatinine-based estimated Glomerular Filtration Rate (eGFR) and a Cystatin C-based eGFR of 70?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of Discordant eGFR Values

The combined creatinine-cystatin C equation (eGFRcr-cys) should be used to determine true kidney function, which in this case calculates to approximately 64 mL/min/1.73 m², confirming Stage 3a CKD rather than normal kidney function. 1, 2

Understanding the Discordance

  • When eGFRcys (70 mL/min/1.73 m²) is higher than eGFRcr (upper 50's), the creatinine-based estimate is typically underestimating true kidney function due to reduced muscle mass, malnutrition, or other non-GFR determinants of creatinine 2

  • This discordance pattern (eGFRcys > eGFRcr by >15 mL/min/1.73 m²) occurs in approximately 8-10% of patients and indicates that creatinine is artificially elevated relative to true kidney function or cystatin C is artificially low 3, 4

  • The creatinine-based eGFR of upper 50's likely overestimates the severity of kidney dysfunction, while the cystatin C-based eGFR of 70 may slightly overestimate kidney function 3

The Combined Equation is Superior

  • KDIGO 2024 guidelines explicitly recommend using eGFRcr-cys when there is discordance between creatinine and cystatin C estimates, as the combined equation demonstrates superior performance across various patient populations 1, 2

  • In cases of discordance, eGFRcr-cys is significantly more accurate than either marker alone, with correct GFR classification rates of 62% compared to 38% for eGFRcr alone and 45% for eGFRcys alone 3

  • When eGFRcr and eGFRcys differ by ≥20%, the combined equation reduces median bias to approximately 1-2 mL/min/1.73 m² compared to 8-15 mL/min/1.73 m² for either marker alone 3, 4

Clinical Implications

  • The combined eGFRcr-cys of approximately 64 mL/min/1.73 m² places this patient in Stage 3a CKD (eGFR 45-59 mL/min/1.73 m²), which requires appropriate CKD management including cardiovascular risk assessment, blood pressure control, and monitoring for progression 2

  • The cystatin C test was actually confirmatory of kidney disease, just not at the severity initially suggested by creatinine alone—the true kidney function is intermediate between the two estimates 1, 2

  • This patient does NOT have normal kidney function (eGFR ≥60 mL/min/1.73 m²) as the cystatin C value of 1.04 mg/L, when combined with creatinine, confirms reduced GFR 2

Medication Dosing Considerations

  • The combined eGFRcr-cys value (~64 mL/min/1.73 m²) should be used for all medication dosing decisions, as the creatinine-based eGFR may underestimate true kidney function, potentially leading to inappropriate dose reductions 2, 5

  • Patients with eGFR discordance have 2.3-fold higher risk of medication-related adverse events when dosing is based on creatinine alone, particularly for renally-cleared medications like vancomycin 5

Factors Contributing to Discordance

  • Low muscle mass is the most common cause of this discordance pattern (eGFRcys > eGFRcr), resulting in lower creatinine generation independent of kidney function 1, 2

  • Other potential contributors include malnutrition, vegetarian/low-protein diet, advanced age, or chronic illness that reduces muscle mass 2, 6

  • Systemic inflammation or high comorbidity burden can lower eGFRcys relative to eGFRcr, though this typically causes the opposite discordance pattern 7

Ongoing Management Algorithm

  • Confirm CKD Stage 3a diagnosis using eGFRcr-cys ≈64 mL/min/1.73 m² and investigate causes of discordance including muscle mass assessment, dietary factors, and medications affecting creatinine secretion 2

  • Repeat both creatinine and cystatin C in 3 months to confirm stability and recalculate eGFRcr-cys, as CKD diagnosis requires persistence of reduced eGFR for ≥3 months 1

  • Monitor for CKD progression with serial eGFRcr-cys measurements rather than relying on creatinine alone, as the combined equation provides more accurate tracking of kidney function changes 2, 3

  • Assess for albuminuria if not already done, as this would provide additional confirmation of kidney damage and help guide prognosis and treatment intensity 1

Common Pitfalls to Avoid

  • Do not dismiss the cystatin C result as "non-confirmatory"—it actually confirms kidney disease at a less severe stage than creatinine alone suggested 2, 3

  • Do not use either eGFRcr or eGFRcys alone for clinical decision-making when discordance exists, as both are less accurate than the combined equation 3, 4

  • Do not assume normal kidney function based on the cystatin C-based eGFR of 70 without calculating the combined equation, which reveals Stage 3a CKD 2

References

Related Questions

What is the management for a patient with impaired renal function and discrepant eGFR estimates between creatinine (58) and Cystatin C (CysC) (70) with normal uACR?
What are the reasons for a discrepancy between an estimated Glomerular Filtration Rate (eGFR) with creatinine and an eGFR adjusted with creatinine?
What to do if eGFR is 70 but unclear if based on creatinine or cystatin C (Cystatin C) with a cystatin C level of 1.04?
What should I do with a patient who has a discrepancy between their estimated Glomerular Filtration Rate (eGFR) with creatinine and cystatin C (43) and their eGFR with creatinine alone (61)?
What causes a discrepancy between estimated Glomerular Filtration Rate (eGFR) measured by creatinine and eGFR measured by cystatin C in patients?
What is a suitable prescription for valsartan (angiotensin II receptor antagonist) in a patient with hypertension, potentially with a history of heart failure, kidney disease, or liver disease, and possibly taking other medications such as diuretics, beta-blockers, or nonsteroidal anti-inflammatory drugs (NSAIDs)?
Should gabapentin be held in a patient with acute kidney injury (Impaired renal function) and a history of chronic pain or neurological conditions?
Can a patient with hypoparathyroidism, kidney disease, or osteoporosis take calcitriol and vitamin D (Vit D) together?
How to manage hypoglycemia (low blood sugar) in patients with a history of type 2 diabetes (T2D) after undergoing bariatric surgery?
What is the recommended dosage and usage of hydroxyzine for an adult patient with anxiety and insomnia, considering potential side effects and interactions with other medical conditions?
What labs should be monitored in a pediatric patient taking risperidone (antipsychotic medication)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.